Van Snick J L, Masson P L, Heremans J F
J Exp Med. 1974 Oct 1;140(4):1068-84. doi: 10.1084/jem.140.4.1068.
The hyposideremia of inflammation was found to be based on a three-step mechanism involving lactoferrin, the iron-binding protein from the specific granules of neutrophilic leukocytes. (a) Lactoferrin is Released from Neutrophils in an Iron-Free Form. When phagocytosis was induced in neutrophils by zymosan or bacteria, lactoferrin was recovered in the incubation medium together with other constituents of the specific granules, such as alkaline phosphatase and lysozyme. Lactoferrin extracted from leukocytes was able to bind the amount of iron corresponding to its theoretical iron-binding capacity. After injection of endotoxin into rats, lactoferrin was detected in various tissues where it was normally absent, or in the plasma when the reticuloendothelial system (RES) had previously been blocked by injections of India ink or aggregated albumin. (b) Lactoferrin is Able to Remove the Iron from Transferrin. Significant exchange of iron from transferrin to lactoferrin was observed in vitro only at a pH below 7.0 or in the presence of a high concentration of citrate. However, the fast elimination of lactoferrin in vivo, when saturated with iron, might account for the observed transfer of iron to endogenous or administered apolactoferrin. Intravenous injection of human apolactoferrin into rats caused a marked decrease of the plasma iron level. The kinetics of this process, as well as controls with other proteins, ruled out the possibility of a secondary inflammatory effect due to phlogogenic contaminants. (c) Fe-Lactoferrin is Taken-up by the RES. By immunofluorescence, lactoferrin was shown to be bound and ingested by monocytes. The rate of elimination of human Fe-lactoferrin injected into rats was particularly fast when compared to that of human apolactoferrin, succinylated Fe-lactoferrin, or other human proteins. Blockade of the RES slowed down the rate of clearance of Fe-lactoferrin and was also found to retard the elimination of endogenous rat lactoferrin released by endotoxin. These experiments suggest the existence of specific receptors for Fe-lactoferrin on the membrane of macrophages.
炎症性低铁血症被发现是基于一个涉及乳铁蛋白的三步机制,乳铁蛋白是嗜中性白细胞特异性颗粒中的铁结合蛋白。(a) 乳铁蛋白以无铁形式从中性粒细胞释放。当用酵母聚糖或细菌诱导中性粒细胞进行吞噬作用时,乳铁蛋白与特异性颗粒的其他成分(如碱性磷酸酶和溶菌酶)一起在孵育培养基中被回收。从白细胞中提取的乳铁蛋白能够结合与其理论铁结合能力相对应的铁量。给大鼠注射内毒素后,在各种正常情况下不存在乳铁蛋白的组织中检测到了乳铁蛋白,或者当网状内皮系统(RES)先前已被注射印度墨水或聚集白蛋白阻断时,在血浆中检测到了乳铁蛋白。(b) 乳铁蛋白能够从转铁蛋白中去除铁。仅在pH低于7.0或存在高浓度柠檬酸盐的情况下,在体外观察到了铁从转铁蛋白到乳铁蛋白的显著交换。然而,当体内的乳铁蛋白被铁饱和时其快速清除,可能解释了观察到的铁向内源性或给予的脱铁乳铁蛋白的转移。给大鼠静脉注射人脱铁乳铁蛋白导致血浆铁水平显著降低。该过程的动力学以及与其他蛋白质的对照排除了由致炎污染物引起的继发性炎症效应的可能性。(c) 铁 - 乳铁蛋白被RES摄取。通过免疫荧光显示,乳铁蛋白被单核细胞结合并摄取。与注射人脱铁乳铁蛋白、琥珀酰化铁 - 乳铁蛋白或其他人类蛋白质相比,给大鼠注射人铁 - 乳铁蛋白后的消除速率特别快。RES的阻断减缓了铁 - 乳铁蛋白的清除速率,并且还发现它延缓了内毒素释放的内源性大鼠乳铁蛋白的消除。这些实验表明巨噬细胞膜上存在铁 - 乳铁蛋白的特异性受体。